Physiologically based synthetic models of hepatic disposition

被引:42
|
作者
Hunt, C. Anthony
Ropella, Glen E. P.
Yan, Li
Hung, Daniel Y.
Roberts, Michael S.
机构
[1] Univ Calif San Francisco, Dept Biopharmaceut Sci, Biosyst Grp, San Francisco, CA 94143 USA
[2] Univ Queensland, Princess Alexandra Hosp, Sch Med, Brisbane, Qld 4102, Australia
基金
英国医学研究理事会;
关键词
physiologically based; liver; modeling (modelling); simulation; discrete event; agent-based;
D O I
10.1007/s10928-006-9031-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Current Physiologically based pharmacokinetic (PBPK) models are inductive. We present an additional, different approach that is based on the synthetic rather than the inductive approach to modeling and simulation. It relies on object-oriented programming A model of the referent system in its experimental context is synthesized by assembling objects that represent components such as molecules, cells, aspects of tissue architecture, catheters, etc. The single pass perfused rat liver has been well described in evaluating hepatic drug pharmacokinetics (PK) and is the system on which we focus. In silico experiments begin with administration of objects representing actual compounds. Data are collected in a manner analogous to that in the referent PK experiments. The synthetic modeling method allows for recognition and representation of discrete event and discrete time processes, as well as heterogeneity in organization, function, and spatial effects. An application is developed for sucrose and antipyrine, administered separately and together PBPK modeling has made extensive progress in characterizing abstracted PK properties but this has also been its limitation. Now, other important questions and possible extensions emerge. How are these PK properties and the observed behaviors generated? The inherent heuristic limitations of traditional models have hindered getting meaningful, detailed answers to such questions. Synthetic models of the type described here are specifically intended to help answer such questions. Analogous to wet-lab experimental models, they retain their applicability even when broken apart into sub-components. Having and applying this new class of models along with traditional PK modeling methods is expected to increase the productivity of pharmaceutical research at all levels that make use of modeling and simulation.
引用
收藏
页码:737 / 772
页数:36
相关论文
共 50 条
  • [21] Engineering Physiologically Relevant Models of Hepatic Insulin Resistance
    Tevonian, Erin
    Jeppesen, Jacob F.
    Lauffenburger, Douglas
    Griffith, Linda G.
    DIABETES, 2022, 71
  • [22] Physiologically based models of stereovision
    Qian, N.
    PERCEPTION, 2001, 30 : 10 - 10
  • [23] Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Caffeine Disposition in Pregnancy
    Darakjian, Lucy I.
    Kaddoumi, Amal
    MOLECULAR PHARMACEUTICS, 2019, 16 (03) : 1340 - 1349
  • [24] Physiologically Based Pharmacokinetic Model of Midazolam Disposition during Pregnancy
    Andrew, Marilee A.
    Hebert, Mary F.
    Vicini, Paolo
    2008 30TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-8, 2008, : 5454 - +
  • [25] Physiologically based pharmacokinetic (PBPK) modeling of disposition of epiroprim in humans
    Luttringer, O
    Theil, FP
    Poulin, P
    Schmitt-Hoffmann, AH
    Guentert, TW
    Lavé, T
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (10) : 1990 - 2007
  • [26] A review of physiologically based pharmacokinetic modeling of renal drug disposition
    Huang, Weize
    Bowman, Christine
    Yin, Mengyue
    Han, Lyrialle W.
    Wen, Yue Winnie
    Ahn, Sara Kim
    Chen, Yuan
    DRUG METABOLISM AND DISPOSITION, 2025, 53 (03)
  • [27] PHYSIOLOGICALLY-BASED MODELS FOR BONE-SEEKING ELEMENTS .5. LEAD ABSORPTION AND DISPOSITION IN CHILDHOOD
    OFLAHERTY, EJ
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 131 (02) : 297 - 308
  • [28] Physiologically Based Pharmacokinetic Models for Infliximab, Ipilimumab, and Nivolumab Developed with GastroPlus to Predict Hepatic Concentrations
    Vallejo, Celeste
    Meaney, Cameron
    Clemens, Lara
    Yang, Kyunghee
    Lukacova, Viera
    Zhou, Haiying
    PHARMACEUTICS, 2025, 17 (03)
  • [29] Physiologically based models of metal kinetics
    O'Flaherty, EJ
    CRITICAL REVIEWS IN TOXICOLOGY, 1998, 28 (03) : 271 - 317
  • [30] PREDICTION OF GLYCYRRHIZIN DISPOSITION IN RAT AND MAN BY A PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL
    ISHIDA, S
    SAKIYA, Y
    ICHIKAWA, T
    TAIRA, Z
    AWAZU, S
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1990, 38 (01) : 212 - 218